Indeed, our previous study showed that re-expression of LZTS1 in the highly metastatic MDA-MB-231 cell line resulted in an inhibition of cancer cell proliferation, migration and invasion, and suppression of epithelial-to-mesenchymal transition [20]. The gene discussed is LZTS1; the disease is cancer.